6:24 PM
 | 
Feb 04, 2015
 |  BC Extra  |  Company News

The Medicines Co. acquires Annovation

The Medicines Co. (NASDAQ:MDCO) exercised its option to acquire Annovation Biopharma Inc. (Cambridge, Mass.) for $28.4 million in cash up front. Annovation shareholders are eligible for up to $26.3 million in clinical and regulatory milestones, plus low-single digit royalties.

The Medicines Co. said Annovation's lead compound...

Read the full 224 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >